🔎 Trials Near Me

Home › Myelodysplastic Syndromes › California › Mountain View

Myelodysplastic Syndromes clinical trials in Mountain View, CA

9 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

RecruitingPhase 1
  • Stanford Health Care, Stanford · 5 mi away
Ages 12 to 78 · All sexes · Updated Sep 29, 2026 · NCT03802695

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

RecruitingPhase 1
  • Lucille Packard Children's Hospital of Stanford University, Palo Alto · 5 mi away
18 Months – 39 Years · All sexes · Updated Aug 21, 2026 · NCT07573111

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

RecruitingPhase 1
  • Stanford University, Palo Alto · 5 mi away
Ages 18 to 80 · All sexes · Updated Aug 17, 2026 · NCT07302776

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

RecruitingPhase 1/2
  • Stanford Cancer Institute, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT05308264

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

RecruitingPhase 1
  • Stanford University, Palo Alto · 5 mi away
Ages 18 to 70 · All sexes · Updated Jun 23, 2026 · NCT06551584

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RecruitingPhase 1/2
  • Stanford University, Palo Alto · 5 mi away
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Stanford · 5 mi away
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

RecruitingPhase 1
  • Stanford Cancer Center, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT06501196

About Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.

More about Myelodysplastic Syndromes on MedlinePlus

Myelodysplastic Syndromes trials in other cities

Other studies in Mountain View

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.